UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | C000000397 |
|---|---|
| Receipt number | R000000422 |
| Scientific Title | Phase II study of sequential administration of FEC (Fluorouracil / Epirubicin / Cyclophosphamide) followed by Docetaxel as adjuvant chemotherapy for node-positive breast cancer |
| Date of disclosure of the study information | 2006/04/06 |
| Last modified on | 2008/12/16 16:18:01 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2006/04/05 13:47:42 | ||
| 2 | Update | 2006/10/24 10:52:53 | ||
| 3 | Update | 2007/04/07 10:34:30 | Division name Division name Email1 |
|
| 4 | Update | 2007/05/07 09:41:02 | Recruitment status |
|
| 5 | Update | 2007/10/05 09:39:45 | Recruitment status Date of closure to data entry Date trial data considered complete Date analysis concluded Publication of results |
|
| 6 | Update | 2007/10/05 09:40:54 | Category of Funding Organization |
|
| 7 | Update | 2008/01/08 09:05:17 | Recruitment status |
|
| 8 | Update | 2008/12/16 16:18:01 | Recruitment status |
